Krystal Biotech, Inc. KRYS Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s operating lease ROU assets?
- Krystal Biotech, Inc. (KRYS) reported operating lease ROU assets of $7.04M in Q1 2026.
- How has Krystal Biotech, Inc.'s operating lease ROU assets changed year-over-year?
- Krystal Biotech, Inc.'s operating lease ROU assets decreased by 10.5% year-over-year, from $7.86M to $7.04M.
- What is the long-term trend for Krystal Biotech, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s operating lease ROU assets has grown at a 17.0% compound annual growth rate (CAGR), from $3.3M to $7.24M.